Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
568
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal

Shiv Kumar Sah1 Little Buddha College of Health Science, Purbanchal University, Minbhawan, Kathmandu, NepalCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8284-5925
ORCID Icon,
Pramod Raj Bhattarai2 National Tuberculosis Control Center, Bhaktapur, Nepal
,
Anjana Shrestha3 Asian College for Advance Studies, Purbanchal University, Satdobato, Lalitpur, Nepal
,
Deepak Dhami3 Asian College for Advance Studies, Purbanchal University, Satdobato, Lalitpur, Nepal
,
Deepa guruwacharya3 Asian College for Advance Studies, Purbanchal University, Satdobato, Lalitpur, Nepal
&
Renu Shrestha3 Asian College for Advance Studies, Purbanchal University, Satdobato, Lalitpur, Nepal
Pages 2911-2919 | Published online: 20 Aug 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tesfaye Andualem Demissie & Dereje Belayneh. (2021) Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia. Infection and Drug Resistance 14, pages 1335-1341.
Read now

Articles from other publishers (6)

Ebtisam S.A. Hassanin, Aliae AR. Mohamed Hussein, Shaimaa S. Abdelrheem, Ebtehal Dongol, Ahmed Hamdy Ahmed Mhsb, Asmaa M. Zahran, Mohamed Zein & Islam G. Sayed. (2023) Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt. Indian Journal of Tuberculosis 70:3, pages 345-355.
Crossref
Mohamed Muhumed Ali, Fitsum Weldegebreal, Getachew Kabew & Kedir Urgesa. (2023) Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia . SAGE Open Medicine 11, pages 205031212211486.
Crossref
Gizachew Taddesse Akalu, Belay Tessema & Beyene Petros. (2022) High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia. PLOS ONE 17:12, pages e0277145.
Crossref
Getu Diriba, Ayinalem Alemu, Habteyes Hailu Tola, Kirubel Eshetu, Bazezew Yenew, Misikir Amare, Biniyam Dagne, Hilina Mollalign, Waganeh Sinshaw, Yeshiwork Abebaw, Getachew Seid, Mengistu Tadesse, Betselot Zerihun, Melak Getu, Shewki Moga, Abyot Meaza, Dinka Fekadu Gamtesa, Zigba Tefera, Amanuel Wondimu, Michael Hailu, Bedo Buta, Muluwork Getahun & Abebaw Kebede. (2022) Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021. IJID Regions 5, pages 97-103.
Crossref
Changli Xie, Xin Hu, Yali Liu & Chengfeng Shu. (2022) Performance Comparison of GeneXpert MTB/RIF, Gene Chip Technology, and Modified Roche Culture Method in Detecting Mycobacterium tuberculosis and Drug Susceptibility in Sputum. Contrast Media & Molecular Imaging 2022, pages 1-5.
Crossref
SharmeenQadr Faqi Abdullah. (2022) Sociodemographic profile of mono rifampicin-resistant (RR) cases among pulmonary tuberculosis patients, Erbil, Iraq, 2015–2020. Medical Journal of Babylon 19:3, pages 441.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.